Home
Clinical Resources Search
PQI: DPYD Testing Prior to Fluoropyrimidine Treatment

DPYD Testing Prior to Fluoropyrimidine Treatment

Last Updated: May 22, 2024

By: Dan Hertz, PharmD, PhD

About this PQI

The purpose of this PQI is to review recommendations for DPYD testing prior to initiation of treatment with fluoropyrimidine based chemotherapy and increase awareness of the clinical benefit of pretreatment DPYD testing.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Cancer Genomics Capecitabine Fluorouracil (5-FU) Xeloda

PQI

Frequently Searched

Supported by

DPYD Testing Prior to Fluoropyrimidine Treatment

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (OGSIVEO®) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E7: A Haven of Healing

S9 E6: Healing Through Sound: A Breast Cancer Journey

S9 E5: Global Health, Cancer Survivorship, and Advancing Equity

S9 E4: Advancing Pharmacogenomics in Oncology

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team

PQI in Action: Larotrectinib (Vitrakvi®) Overview

PQI: Selpercatinib (Retevmo®) Genomic Testing Management

PQI Podcast S6 Ep 2: Molecular Testing & Targeted Treatment in Colorectal Cancer

PQI Podcast S6 Ep 9: ctDNA Testing in GI Cancers

Capecitabine and Mitomycin with Radiation Therapy

Tislelizumab, Capecitabine, and Cisplatin

Pembrolizumab, Capecitabine, and Cisplatin

Tislelizumab and CAPOX

Fluorouracil and Mitomycin with Radiation Therapy

Fluorouracil (5-FU), Leucovorin, Oxaliplatin, and Docetaxel (FLOT)

Pembrolizumab, Fluorouracil, and Cisplatin

Nivolumab, Fluorouracil, and Cisplatin

Capecitabine and Mitomycin with Radiation Therapy

Tislelizumab, Capecitabine, and Cisplatin

Pembrolizumab, Capecitabine, and Cisplatin

Tislelizumab and CAPOX

Bortezomib

Capecitabine and Mitomycin with Radiation Therapy

Fluorouracil and Mitomycin with Radiation Therapy

Bortezomib and Dexamethasone